Pulmatrix Inc Share Price Nasdaq
Equities
US74584P1030
Biotechnology & Medical Research
Sales 2022 | 6.07M 506M | Sales 2023 | 7.3M 608M | Capitalization | 6.79M 566M |
---|---|---|---|---|---|
Net income 2022 | -18M -1.5B | Net income 2023 | -14M -1.17B | EV / Sales 2022 | -3.4 x |
Net cash position 2022 | 34.77M 2.9B | Net cash position 2023 | 10.42M 868M | EV / Sales 2023 | -0.5 x |
P/E ratio 2022 |
-0.71
x | P/E ratio 2023 |
-0.48
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Teofilo Raad
CEO | Chief Executive Officer | 54 | 03/17/03 |
Peter Ludlum
DFI | Director of Finance/CFO | 68 | 18/22/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Batycky
BRD | Director/Board Member | 56 | 01/19/01 |
Director/Board Member | 54 | 23/20/23 | |
Todd Bazemore
BRD | Director/Board Member | 53 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |